MSF launches online resource to combat unwarranted drug patent requests

New ‘Patent Opposition Database’ aims to boost access to medicines in countries increasingly hit by high drug prices Geneva, October 5, 2012 – The international medical humanitarian organization Médecins Sans Frontières (MSF) / Doctors Without Borders has launched an online resource to help civil society and patient groups in developing countries challenge unwarranted drug patents. … Read more

Novartis challenge against India’s pro-health patent law heads to supreme court

NEW DELHI/GENEVA/NEW YORK, SEPTEMBER 11, 2012—The Swiss pharmaceutical company Novartis heads to the Indian Supreme Court today in New Delhi, in a final bid to undermine a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusive patenting practices that keep medicine prices high, the international medical humanitarian organization … Read more

India: Novartis Challenges Pro-health Patent Law

Swiss pharmaceutical company Novartis heads to the Indian Supreme Court today in New Delhi, in a final bid to undermine a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusive patenting practices which keep medicine prices high. If successful, the move would have a devastating impact on access … Read more

Afghanistan: MSF treats victims of bomb blast in Kunduz

KABUL/NEW YORK, SEPTEMBER 10, 2012—Following a major explosion today in the city of Kunduz in northern Afghanistan, more than two dozen people arrived at a surgical hospital run by the international medical humanitarian organization Médecins Sans Frontières (MSF) / Doctors Without Borders. Thirteen people who suffered severe blast injuries were dead on arrival at the … Read more

2012 J. William Fulbright Prize For International Understanding

WASHINGTON, DC/NEW YORK, SEPTEMBER 8, 2012 – The Fulbright Association presented its 2012 J. William Fulbright Prize for International Understanding to Doctors Without Borders/Médecins Sans Frontières (MSF), the international medical humanitarian organization. The formal award ceremony took place on September 8, 2012, at the Library of Congress in Washington, D.C. The award, a $50,000 prize, … Read more

Doctors without borders to receive 2012 J. William Fulbright Prize for International Understanding

First Time Prize Awarded to Organization, Rather Than to an Individual WASHINGTON, DC/NEW YORK, SEPTEMBER 6, 2012—The Fulbright Association will present its 2012 J. William Fulbright Prize for International Understanding to the international medical humanitarian organization Médecins Sans Frontières (MSF) / Doctors Without Borders. The formal award ceremony is scheduled for September 8, 2012, at … Read more

Bayer attempting to block affordable patented drugs In India

Geneva/New Delhi, September 3, 2012 – German pharmaceutical company Bayer today heads to India’s Intellectual Property Appellate Board in Chennai in a bid to overturn a compulsory licence that has allowed more affordable generic versions of sorafenib tosylate, a cancer drug patented by Bayer, to be produced in the interests of public health. International humanitarian … Read more